Refresh

Ankur Drugs & Pharma Ltd. - Research Center

531683 ANKURDRUGS Group (T) BSE data
Back to Company

Results

Statement

More

Half Yearly results in brief
(Rs crore)
Sep ' 12 Mar ' 12 Sep ' 11 Mar ' 11 Sep ' 10

Sales

68.78 76.44 76.65 271.42 552.57

Operating profit

-3.71 -18.88 -17.75 14.40 118.21

Interest

50.17 50.95 17.01 57.41 55.34

Gross profit

-53.86 -69.81 -34.72 -42.60 63.27

EPS (Rs)

-44.96 -80.74 -33.81 -52.15 18.07
Half yearly  results in details
Sep ' 12 Mar ' 12 Sep ' 11 Mar ' 11 Sep ' 10

Other income

0.03 0.02 0.04 0.41 0.40

Stock adjustment

-0.55 5.39 13.29 46.80 -7.18

Raw material

47.91 55.35 38.58 168.66 403.09

Power and fuel

- - - - -

Employee expenses

10.90 13.68 15.23 16.97 12.76

Excise

- - - - -

Admin and selling expenses

- - - - -

Research and development expenses

- - - - -

Expenses capitalised

- - - - -

Other expenses

14.22 20.89 22.40 24.59 25.70

Provisions made

- - 4.90 - -

Depreciation

33.10 31.73 30.68 41.12 19.69

Taxation

- 31.27 - 20.11 8.63

Net profit / loss

-86.96 -156.17 -65.40 -100.87 34.95

Extra ordinary item

- -23.37 - 2.95 -

Prior year adjustments

- - - - -

Equity capital

19.34 19.34 19.34 19.34 19.34

Equity dividend rate

- - - - -

Agg.of non-prom. shares (Lacs)

170.40 161.21 158.19 146.02 144.36

Agg.of non promotoholding (%)

88.10 83.35 81.79 75.49 74.64

OPM (%)

-5.40 -24.69 -23.16 5.31 21.39

GPM (%)

-78.27 -91.30 -45.28 -15.67 11.44

NPM (%)

-126.38 -204.26 -85.28 -37.11 6.32
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com